Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| PROTALIX BIO | PLX | 5.71% |
| SONIC FOUNDR | SOFO | 5.07% |
| SUMITOMO MIT | SMFG | 4.33% |
| TOKIO MARINE | TKOMY | 3.56% |
| STATE AUTO F | STFC | 3.37% |
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Full Analysis
Crocs, Inc. and its subsidiaries design, develop, and manufacture consumer products from specialty resins worldwide. It offers footwear for men, women, and children under the crocs brand. The company also offers apparel and accessories, including t-shirts, sweatshirts, hats, beanies, and socks.
In addition, it manufactures spa pillows for the home spa market; seats and pads for use in kayaks and canoes; and scuba diving fins for other water sports products, as well as produces and distributes hockey and lacrosse equipment. It sells its products through other specialty channels, including gift shops, uniform suppliers, independent bicycle dealers, specialty food retailers, health and beauty stores, and other specialty stores.
The company recently announced that it will be introducing its first apparel line this October. Crocs noted that Select pieces in the men's apparel collection incorporate a new form of Crocs' proprietary material, Croslite(TM), already known in Crocs(TM) footwear. The added that the new material, Croslite rt(TM), which stands for "relaxed technology", makes garments lightweight, versatile, breathable, and durable. Croslite rt(TM) also enables garments to be resistant to harsh chemicals and heat, ensuring longevity after exposure to sun, UV light and sweat.
CROX hit a 52-week high on the day it announced the unveiling of its apparel line and it currently trades slightly below that level.
In late July, Crocs announced that it has entered into a definitive agreement to acquire the Bite Footwear brand for $1.75 million in cash, plus a potential earn-out of up to $1.75 million based on Bite hitting certain earnings targets over a three-year period. Crocs stated that Bite has created a portfolio of exciting and innovative footwear products that will be a terrific compliment to Crocs existing business. Like Crocs, Bite Footwear utilizes patented technology to provide consumers with comfort, support and functionality across several target markets.
A few days prior to the Bite Footwear announcement, CROX reported second-quarter results. Earnings per share of 58 cents soared past the year-prior 19 cents and topped the consensus estimate by 32%. Second-quarter revenues shot up 162% on a year-over-year basis. The company raised its year 2007 outlook. Crocs now expects full-year earnings to range between $1.89 and $1.93 per share. Analyst are currently expecting earnings of $1.97 per share for 2007. Wall Street estimates stood at $1.53 two months ago.
Get the full Snapshot Report on CROX - FREE